Last reviewed · How we verify

NCT06046365

Early Diagnosis of Breast Cancer-related Lymphedema

Recruiting now Last updated 11 June 2025
What this trial tests

trial testing lymphoscintigraphy in Lymphedema in 300 participants. Currently enrolling.

Timeline
24 October 2022
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorKaohsiung Veterans General Hospital.
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment300
Start date24 October 2022
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Kaohsiung Veterans General Hospital.

Who can join

Adults 20 to 80, female only, with Lymphedema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will conduct clinical trials to explore the mechanisms behind the development of upper limb lymphedema following breast cancer surgery. The investigators will recruit patients who have undergone breast cancer surgery and utilize Indocyanine Green (ICG) lymphography and Lymphoscintigraphy to identify the locations of lymphatic blockages. Shear Wave Elastography (SWE) will be used to detect changes in tissue limb compliance. DXA body composition analysis will measure the differences in the composition ratios between edematous and normal limbs. In addition, diffusion correlation spectrometry will be employed to monitor changes in deep tissue blood flow, complemented by continuous measurements of limb circumference and other physiological parameters. The study aims to explore the interrelationships among lymphatic circulation, limb circumference, tissue compliance, and tissue blood flow rates.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lymphedema

Currently open trials in the same condition.

Other Kaohsiung Veterans General Hospital. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06046365.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing